Spirometry: Don't blow it!

Chest

Volumn 136, Issue 2, 2009, Pages 608-614

  Lange, Nancy E ^a   Mulholland, Mary ^a   Kreider, Mary Elizabeth ^a,b  

^a HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHRONIC OBSTRUCTIVE LUNG DISEASE; FORCED EXPIRATORY VOLUME; HISTORY OF MEDICINE; HUMAN; LUNG FUNCTION TEST; MEDICAL INSTRUMENTATION; MEDICARE; MORTALITY; NOMENCLATURE; PATIENT SAFETY; PRIORITY JOURNAL; REFERENCE VALUE; REIMBURSEMENT; RESPIRATORY TRACT DISEASE; REVIEW; SPIROMETRY; TECHNIQUE;

EID: 68849095532     PISSN: 00123692     EISSN: 19313543     Source Type: Journal    
DOI: 10.1378/chest.08-2315     Document Type: Article

References (31)

1. Medical directory: search for companies or produces worldwide; a short history of spirometry and lung function tests. Available at: http://medizin.li/spirometer/spirometer-history.html. Accessed May 15, 2009
2. Petty TL. John Hutchinson's mysterious machine revisited. Chest 2002; 121:219S-223S
3. Milic-Emili JML, D'Angelo E. 150 years of blowing: since John Hutchinson. Can Respir J 1997; 4:239-245
4. Yernault JC. The birth and development of the forced expiratory manoeuvre: a tribute to Robert Tiffeneau (1910-1961). Eur Respir J 1997; 10:2704-2710
5. Miller MR, Hankinson J, Brusasco V, et al. Standardisation of spirometry. Eur Respir J 2005; 26:319-338
6. American Thoracic Society. Standardization of spirometry, 1994 update. Am J Respir Crit Care Med 1995; 152:1107-1136
7. Crapo RO, Jensen RL. Standards and interpretive issues in lung function testing. Respir Care 2003; 48:764-772
8. Miller MR, Crapo R, Hankinson J, et al. General considerations for lung function testing. Eur Respir J 2005; 26:153-161
9. Gudmundsson G, Cerveny M, Shasby DM. Spirometric values in obese individuals: effects of body position. Am J Respir Crit Care Med 1997; 156:998-999
10. Lung function testing: selection of reference values and interpretative strategies: American Thoracic Society. Am Rev Respir Dis 1991; 144:1202-1218
11. Enright PL. How to make sure your spirometry tests are of good quality. Respir Care 2003; 48:773-776
12. Guberan E, Williams MK, Walford J, et al. Circadian variation of F.E.V. in shift workers. Br J Ind Med 1969; 26:121-125
13. Stoller JK, Basheda S, Laskowski D, et al. Trial of standard versus modified expiration to achieve end-of-test spirometry criteria. Am Rev Respir Dis 1993; 148:275-280
14. Eaton T, Withy S, Garrett JE, et al. Spirometry in primary care practice: the importance of quality assurance and the impact of spirometry workshops. Chest 1999; 116:416-423
15. Bucca CB, Carossa S, Colagrande P, et al. Effect of edentulism on spirometric tests. Am J Respir Crit Care Med 2001; 163:1018-1020
16. D'Angelo E, Prandi E, Marazzini L, et al. Dependence of maximal flow-volume curves on time course of preceding inspiration in patients with chronic obstruction pulmonary disease. Am J Respir Crit Care Med 1994; 150:1581-1586
17. Coates AL, Desmond KJ, Demizio D, et al. Sources of variation in FEV1. Am J Respir Crit Care Med 1994; 149: 439-443
18. Hankinson JL, Odencrantz JR, Fedan KB. Spirometric reference values from a sample of the general U.S. population. Am J Respir Crit Care Med 1999; 159:179-187
19. Pellegrino R, Viegi G, Brusasco V, et al. Interpretative strategies for lung function tests. Eur Respir J 2005; 26:948-968
20. Executive summary: global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. Available at: http://www.goldcopd.org/Guidelineitem.asp?l1=2&l2=1&intId=996. Accessed July 6, 2009
21. Kreider ME, Grippi MA. Impact of the new ATS/ERS pulmonary function test interpretation guidelines. Respir Med 2007; 101:2336-2342
22. Enright P. Flawed interpretative strategies for lung function tests harm patients. Eur Respir J 2006; 27:1322-1323
23. Hole DJ, Watt GC, Davey-Smith G, et al. Impaired lung function and mortality risk in men and women: findings from the Renfrew and Paisley prospective population study. BMJ 1996; 313:711-715
24. Peto R, Speizer FE, Cochrane AL, et al. The relevance in adults of air-flow obstruction, but not of mucus hypersecretion, to mortality from chronic lung disease: results from 20 years of prospective observation. Am Rev Respir Dis 1983; 128:491-500
25. Schunemann HJ, Dorn J, Grant BJ, et al. Pulmonary function is a long-term predictor of mortality in the general population: 29-year follow-up of the Buffalo Health Study. Chest 2000; 118:656-664
26. Young RP, Hopkins R, Eaton TE. Forced expiratory volume in one second: not just a lung function test but a marker of premature death from all causes. Eur Respir J 2007; 30:616-622
27. Friedman GD, Klatsky AL, Siegelaub AB. Lung function and risk of myocardial infarction and sudden cardiac death. N Engl J Med 1976; 294:1071-1075
28. Buffels J, Degryse J, Decramer M, et al. Spirometry and smoking cessation advice in general practice: a randomised clinical trial. Respir Med 2006; 100:2012-2017
29. Screening for chronic obstructive pulmonary disease using spirometry: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med 2008; 148:529-534
30. Diamond E. Pulmonary function and exercise testing. In: Manaker S, ed. Appropriate coding for critical care services and pulmonary medicine 2007. New Berlin, WI: Northbrook, 2007; 161-175
31. Beebe M, Dalton JA, Espronceda M, et al. CPT 2007 professional edition. Chicago, IL: American Medical Association, 2007; 400